TWIM
AZN icon

TIAA Wealth Investment Management’s AstraZeneca AZN Stock Holding History

TIAA Wealth Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$336K Buy
1,773
+116
+7% +$21.8K ﹤0.01% 266
2026
Q1 		$327K Buy
+1,657
New +$319K ﹤0.01% 240

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return

TIAA Wealth Investment Management's AZN Position: Q2 2026 in Review

TIAA Wealth Investment Management increased its AstraZeneca (AZN) stake by 7% in Q2 2026, buying an estimated $21.8K and bringing the position to 1,773 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #266.

TIAA Wealth Investment Management first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. 1,425 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • TIAA Wealth Investment Management held 1,773 shares of AstraZeneca worth $336K as of Q2 2026.
  • TIAA Wealth Investment Management bought 116 AstraZeneca shares in Q2 2026, an estimated $21.8K.
  • AstraZeneca made up ﹤0.01% of TIAA Wealth Investment Management's portfolio in Q2 2026, its #266 holding.
  • TIAA Wealth Investment Management first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
  • 1,425 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on TIAA Wealth Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.